← Back to catalogue

TheraPEAK™ Lymphocyte Separation Medium

FDA UDI

Class I (US FDA UDI)

by Lonza Walkersville, Inc.

Identity

Trade Name
TheraPEAK™ Lymphocyte Separation Medium FDA UDI
Generic Name
Ex vivo cell culture medium FDA UDI
Model / Reference
BP17-829E FDA UDI

Identifiers

Catalog Number
BP17-829E FDA UDI
Primary DI / UDI-DI
00840075400370 FDA UDI
FDA Product Code
KIT FDA UDI
GMDN Term
Ex vivo cell culture medium FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
864.2220 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Ex vivo cell culture medium

TheraPEAK™ Lymphocyte Separation Medium by Lonza Walkersville, Inc. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Ex vivo cell culture medium.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 40f85af3-1286-4554-8ae3-18640a1f9d8f 33 fields · synced May 31, 2026